February 2022

23
Feb

Four tips to mitigate the risk of single source IVD assay manufacturing

How secure is your assay manufacturing? Manufacturing in vitro diagnostic (IVD) assays in-house, or outsourcing to a single contract manufacturer, should result in the seamless integration of technology transfer, pilot batch production, validation and verification, regulatory submission and subsequently efficient large-scale output. After all, if all those processes are managed in one place the surely there is tighter control? But

Read more

17
Feb

Selecting the right contract manufacturer for in vitro diagnostic assays: your 12-point checklist

Increased throughput, improved efficiency, reduced risk There are many reasons you might consider a new assay manufacturing partner. You may need to ramp up production quickly to meet increasing demand, or you could be looking to reduce production costs. Perhaps you want to mitigate the risk of a single source of supply, or perhaps an issue with an incumbent supplier

Read more

3
Feb

Biofortuna supports World Cancer Day

We are proud to support the UICC’s World Cancer Day initiative